Table 1.
Author, year | Data from | Study type | Time | Age | Female (%) | Case | Total | Bmi | Follow-up time | Dietary assessment mode | Diet type | Outcome | Adjust |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dong D Wang, 2022 | MVP | Cohort study | 2011–2018 | 65.5 | 8.1 | 31,316 | 315,919 | / | 4 year | SFFQ | PDI hPDI uPDI |
All mortality, CVD mortality, cancer mortality, other mortality | Age (years: < 60, 60–70, > 70) and sex (male or female); race/ethnicity (non-Hispanic European American, African American or other), education level (≤ high school or GED, some colleague, or college or above), income level (< $30,000, $30,000–$59,000 or ≥ $60000)and marriage status (currently married or not), smoking status (current, former or never smoking), frequency of alcohol consumption (never, < 1 times/week or ≥ 1 times/week), frequency of exercise vigorously (never/rarely, 1–4 times/month,2–4 times/week or ≥ 5 times/week), total energy intake (in quintiles) and BMI (< 23.0, 23.0–24.9, 25.0–29.9, 30.0–34.9 or ≥ 35.0 kg/m2).histories of diabetes, hypertension, hypercholesterolemia, cancer and CVD at baseline (yes vs. no). |
Hairong Li, 2022 | The US National Health and Nutrition Examination Survey (NHANES). | Cohort study | 1999–2014 | 47.3 | / | 4,904 | 40,074 | / | 7.8 year | 24-h dietary assessment | PDI hPDI uPDI |
All mortality, CVD mortality, cancer mortality | Sex (male, female), age (spline variables in the analyses with three knots), and total energy intake (spline variables in the analyses with three knots); race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic or other race), education (≤12th grade, high school graduate/GED or equivalent, or more than high school), marital status (married, widowed/divorced/separated, or never married), ratio of family income to poverty (<1.30, 1.30–3.49, or ≥ 3.50), physical activity (<8.3, 8.3–16.7, or > 16.7 METS h/week), smoking (never smokers, former smokers, or current smokers), drinking (never drinking, low to moderate drinking, heavy drinking), body mass index (<18.5, 18.5–24.9, 25.0–29.9, and ≥ 30.0), diabetes (no, yes), hypertension (no, yes), other CVDs (no, yes), and cancer (no, yes) |
Hui Chen, 2022 | CLHLS | Cohort study | 2008–2018 | 86.9 | 57.4 | 8,937 | 13,154 | 20.3 | 5.7 year | FFQ | PDI hPDI uPDI |
All mortality | Age (years), sex (male or female), ethnicity (Han or non-Han), residential area (urban or rural), marital status (married, not married or bereaved), household income (low, medium or high), education (years), smoking status (former smoker, current smoker or never smoker), alcohol intake (former drinker, current drinker or never drinker), regular exercise (yes or no) and baseline BMI (kg m−2). |
Hyunju Kim, 2019 | ARIC study Coordinating Center | Cohort study | 1987–2016 | 53.8 | 55.2 | 5,436 | 12,168 | / | 25 year | The 66‐item semi-quantitative Willett food frequency questionnaire | PDI hPDI uPDI |
All mortality, CVD mortality | Age, sex, race‐center, total energy intake, education, smoking status, physical activity, alcohol consumption, and margarine consumption |
Ijeamaka C. Anyene, 2021 | The Pathways Study | Cohort study | 2005–2013 | 60 | 100% | 653 | 3,646 | 28 | 9.51 year | Block 2005 Food Frequency Questionnaire (FFQ) | PDI hPDI uPDI |
All mortality, breast-cancer-specific mortality | Age at diagnosis, total energy intake (kcal/d), and physical activity (moderate-vigorous MET-hours/week); race/ethnicity, education, menopausal status, smoking status, and stratified by tumor stage and ER status |
Ilka Ratjen, 2021 | The Biobank popgen | Cohort study | 2004–2016 | 69 | 44% | 204 | 1,404 | 26.2 | 7 year | FFQ | PDI hPDI uPDI |
All mortality | Sex, age at diet assessment, BMI, physical activity, survival time from CRC diagnosis until diet assessment, tumor location, metastases, other cancer, type of therapy, smoking status, alcohol intake, total energy intake, time × age, time × BMI, and time × metastases. |
Jihye Kim, 2021 | A population-based cohort in the Korean Genome and Epidemiology Study_Health Examinees | Cohort study | 2004–2019 | 52.7 | 65% | 3,074 | 118,577 | 23.9 | / | Semi-quantitative food frequency questionnaire (FFQ) | PDI hPDI uPDI |
All mortality, CVD mortality, cancer mortality | Age (continuous), sex (men/women), education (≤6, 7e12, >12 years), smoking status (never/former/current), alcohol consumption (never/former/current), energy intake (continuous), physical activity (yes/no), body mass index (continuous), and disease history (yes/no). |
Leah J Weston, 2022 | Jackson Heart Study (JHS) | Cohort study | 2000–2018 | 53.8 | 64 | 597 | 3,635 | 31.75 | 15 year | Delta NIRI FFQ | PDI hPDI uPDI |
All mortality | Age, sex, and total energy intake. educational attainment, smoking status, alcohol intake, margarine intake, and physical activity, body mass index, total cholesterol, hypertension, diabetes, estimated glomerular filtration rate, hormone replacement therapy medication use, and statin medication use. |
Lihui Zhou, 2024 | UK Biobank | Cohort study | 2006–2010 | 55.99 | 54.30% | 9,335 | 189,003 | 26.87 | 9.6 year | The Oxford WebQ dietary questionnaire | PDI hPDI uPDI |
All mortality, Cardiovascular (I), Ischemic heart disease (I20–I25) cancer mortality, Neoplasm (C00-C49), Hematopoietic (C80-97), Respiratory (J), Neurological (G), Mortality | Age, menopausal status or hormone replacement use in females, ethnicity, education, and quintiles of the Townsend deprivation index, familial history of diseases (CVD, diabetes or cancers); smoking status, alcohol drinking frequency, body mass index, physical activity, sedentary time, total dietary energy intake, multivitamin supplement use, and the Charlson Comorbidity Index with the lowest quintiles as references |
M Delgado-Velandia, 2022 | ENRICA, the National Death Index of Spain | Cohort study | 2008–2020 | 47 | 54.50% | 699 | 11,825 | 26.94 | 10.9 year for Mortality 9.8 year for CVD mortality | Electronic diet history (HD-ENRICA) | hPDI uPDI |
All mortality, CVD mortality | Age (years), sex (men, women), and education (≤primary, secondary, and university), smoking status (never, former, and current smoker), body mass index (kg/m2), energy intake (kcal/day), alcohol intake (never drinker, former drinker, moderate alcohol intake, excessive alcohol intake), recreational physical activity (tertiles), number of chronic diseases (continuous), and number of medications taken (continuous). |
Qian Wang, 2023 | At the Shengjing Hospital of China Medical University | Cohort study | 2018–2021 | 61.1 | 30.64 | 240 | 408 | 22.7 | 40.97 months | Semi-quantitative food frequency questionnaire (FFQ) | PDI hPDI uPDI |
All mortality | Adjusted for age at diagnosis (≥60, <60 years), sex (male, female) and total energy intake (continuous, kcal/d). Additionally adjusted for race(Han, others), region (city, rural), education (junior secondary school or below, senior high school/technical secondary school, junior college/university or above), income per month (<5,000, 5,000–10,000, ≥10,000 RMB), marital status (married, unmarried/divorced/widowed), smoking status (yes, no), alcohol intake (continuous, g/d), diet change (yes, no), BMI (continuous, kg/m2), physical activity (MET-hours per week), histological type (small cell lung cancer, non-small lung cancer), AJCC stage (I–II, III–IV), comorbidities (yes, no), surgery (yes, no), chemotherapy (yes, no), radiotherapy (yes, no), targeted treatment (yes, no), and immunotherapy (yes, no). |
Saira Amir, 2024 | The CRIC Study | Cohort study | 2003–2008 | 58 | 52.3 | 836 | 2,539 | 31.9 | 12 year | The National Cancer Institute Diet History Questionnaire (DHQ) | PDI hPDI uPDI |
All mortality | Clinical site, age, sex, race, education, income, total energy intake, physical activity, smoking status, and alcohol use. Obesity status (categorical variable with cut off at 30 kg/m2), kidney function (estimated glomerular filtration rate), 24-hour urinary protein, diabetes, hypertension, history of cardiovascular disease, and use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. |
Zhilei Shan, 2023 | NHS | Cohort study | 1984–2020 | 50.2 | 100 | 31,263 | 75,230 | / | 36 year | Semi-quantitative food frequency questionnaire (FFQ) | hPDI | All mortality, Cardiovascular disease, Heart disease, Stroke, Cancer, Respiratory disease, Neurodegenerative disease | Multivariable analysis was adjusted for age, calendar year, race and ethnicity (NHS: Hispanic, non-Hispanic Black, non-Hispanic White, or other; HPFS, Black, White, or other), marriage status (married; divorced, separated, or single; or widowed), living status (alone or not alone), family history of myocardial infarction (yes or no), family history of diabetes (yes or no), family history of cancer (yes or no), menopausal status (pre- or postmenopausal [never, past, or current menopausal hormone use]; NHS only), multivitamin use (yes or no), aspirin use (yes or no), total energy intake (quintile), smoking status (never, former, or current smoker [1–14, 15–24, or ≥ 25 cigarettes/d]), alcohol drinking (0, 0.1–4.9, 5.0–14.9, 15.0–19.9, 20.0–29.9, or ≥ 30 g/d), physical activity (quintile), history of hypertension (yes or no), history of hypercholesterolemia (yes or no), and body mass index (<21, 21–24.9, 25–29.9, 30–34.9, or ≥ 35 [calculated as weight in kilograms divided by height in meters squared]). |
HPFS | Cohort study | 1986–2020 | 53.3 | 0 | 22,900 | 44,085 | / | 34 year | Semi-quantitative food frequency questionnaire (FFQ) | ||||
Jihye Kim, 2024 | MEC | Cohort study | 1993–2019 | 59 | / | 65,087 | 144,729 | Men 26.6 Women 26.2 |
21.3 year | QFFQ | PDI hPDI uPDI |
All mortality, CVD mortality, cancer mortality | Age at cohort entry, race and ethnicity, education, marital status, history of diabetes, body mass index, smoking status, pack-years of cigarette, physical activity, menopausal hormone therapy use for women only, alcohol consumption, and total energy intake |
The extracted research topics, first authors, data sources, study types, study periods, demographic characteristics of participants (age, sex, quantity, and BMI), follow-up time, dietary assessment methods, study outcomes (types of mortality), adjusted HR or RR and the adjusted variables for each outcome were analysed.